UNLOCKD Reports 76% Month-Over-Month Revenue Growth at Ancient Extracts Following Acquisition

UNLOCKD Inc. announces a 76% month-over-month revenue increase for its subsidiary Ancient Extracts, signaling strong early commercial momentum post-acquisition.

SD Metrowire Staff
Business
UNLOCKD Reports 76% Month-Over-Month Revenue Growth at Ancient Extracts Following Acquisition

UNLOCKD Inc. (OTCID: BFCH), doing business as UNLOCKD, provided a commercialization update for its recently acquired operating subsidiary, VerdaGenix LLC d/b/a Ancient Extracts USA, highlighting encouraging early operating results. Preliminary May 2026 revenue reached approximately $22,344, representing a 76% increase from April 2026 revenue of approximately $12,670. The Company noted that operations commenced under UNLOCKD ownership during the middle of May following the closing of the acquisition, meaning the reported May revenue reflects only a partial month of operations under Company ownership.

On June 2, 2026, Ancient Extracts received a purchase order representing approximately $58,823 in retail product value, with an order total of approximately $29,411 under wholesale pricing terms. All financial figures disclosed are preliminary, unaudited, and subject to further review and adjustment.

“We remain in the early stages of integrating Ancient Extracts into the UNLOCKD organization, but we are encouraged by the commercial momentum we are seeing,” stated John P. Gorst, Chief Executive Officer of UNLOCKD. “The combination of accelerating revenue, customer demand, and expanding distribution opportunities reinforces our belief that Ancient Extracts possesses many of the qualities that originally attracted us to this acquisition. Our focus remains on disciplined execution, strengthening operations, expanding distribution, and creating long-term shareholder value through sustainable growth.”

Ancient Extracts USA offers a growing portfolio of functional mushroom products, ceremonial teas, cacao blends, matcha products, shilajit, and wellness-focused consumer goods marketed under the brand philosophy of “Ancient Remedies for Modern Life.” The Company believes the brand is well positioned to benefit from growing consumer interest in functional mushrooms, adaptogens, botanical wellness products, and evidence-informed approaches to health and human performance. Management believes Ancient Extracts provides UNLOCKD with a capital-efficient operating foundation from which to pursue additional commercialization opportunities, strategic partnerships, product innovation, and long-term expansion initiatives.

Dr. Jordan P. Balencic, Chairman and Chief Science Officer of UNLOCKD, commented: “When we evaluated Ancient Extracts, we believed the business possessed a number of attractive characteristics, including a differentiated product portfolio, a loyal customer base, a capital-efficient operating model, and multiple pathways for future growth. While it remains early in the integration process, the initial operating results and commercial traction we are seeing continue to reinforce our conviction in the opportunity.” Dr. Balencic continued: “Our objective is straightforward: grow revenue, expand distribution, strengthen our portfolio of wellness assets, and execute with discipline. We believe Ancient Extracts provides a strong operating nucleus capable of supporting broader growth initiatives across wellness, functional nutrition, cognitive health, and human optimization. We remain focused on creating durable long-term value through operational execution rather than promotional activity.”

Separately, UNLOCKD announced that its UNLOCKD Technologies division has begun preliminary planning activities related to future consumer health technology opportunities. Management has initiated early-stage evaluation of certain point-of-care testing concepts and has engaged in preliminary discussions with developers, suppliers, and potential strategic partners. These initiatives remain in the conceptual and planning stages. The Company expects any future technology development efforts to follow a disciplined, milestone-driven approach and anticipates pursuing dedicated financing for such initiatives rather than utilizing capital intended for current operating activities. No assurances can be provided regarding the timing, financing, development, regulatory pathway, or commercial success of any future technology initiatives.

For more information, visit www.unlockdinc.com. Follow @BFCHco on X for verified company updates. View the original release on www.newmediawire.com.

Blockchain Registration

QR Code for Blockchain Registration